Stephen P Juraschek, MD, PhD, FAHA, AHSCP-CHS

Présence dans les classements

Les meilleurs jours où les posts de ce compte sont entrés dans le top quotidien de Debya.

Ce compte n’est encore apparu dans aucun classement quotidien.

Posts aimés récemment

J’aime publics du réseau Bluesky.

• American Journal of Hypertension@amjhypertension.bsky.social02/10/2026 15:21

  #HotOffThePress Effects of Anti-Hypertensive Agents on Orthostatic Changes: Secondary Analysis of the Treatment of Mild Hypertension Study (TOMHS) academic.oup.com/ajh/advance-...

  Voir le post
• Marwah Abdalla, MD MPH@marwahabdalla.bsky.social26/05/2026 17:17

  We have more ways to measure blood pressure than ever before but not necessarily more confidence in what those measurements mean. Our NHLBI workshop report in @jaccjournals.bsky.social chaired w/ @spjuraschek.bsky.social provides an implementation roadmap. www.sciencedirect.com/science/arti...

  Voir le post
• Andrew Michael South, MD, MS@asouth-neph.bsky.social13/05/2026 00:27

  Terrific to learn from and work with you @spjuraschek.bsky.social and so many of the fantastic #Hypertension folks out there #BloodPressure #LifeSpan www.sciencedirect.com/science/arti...

  Voir le post
• Alex Chang, MD@alexchangmd.bsky.social22/04/2026 18:50

  Interesting paper - Factors Associated With Discussing High Blood Pressure Readings in Clinical Notes. Naturally, nephrology, transplant, internal med are discussing the most (it's part of the job). ID, endocrine, sports medicine and GI > than cardiology? pubmed.ncbi.nlm.nih.gov/39661402/

  Voir le post
• Iain Bressendorff, MD PhD@ibressendorff.bsky.social19/04/2026 11:34

  Huge fan of spiro, but wouldn’t use it first-line if I didn’t suspect hyperaldosteronism. No CVD outcome data and the side effects for men are not trivial. Don’t feel that the modest effect on BP in primary HTN justifies its use over A/C/D.

  Voir le post

Connectez-vous pour en voir plus

Comptes bloqués

Sur Bluesky, les blocages sont publics.

Ce compte ne bloque personne.